These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 21779722)

  • 1. Insights into Alzheimer disease pathogenesis from studies in transgenic animal models.
    Schaeffer EL; Figueiro M; Gattaz WF
    Clinics (Sao Paulo); 2011; 66 Suppl 1(Suppl 1):45-54. PubMed ID: 21779722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mouse models of Alzheimer's disease.
    Elder GA; Gama Sosa MA; De Gasperi R
    Mt Sinai J Med; 2010; 77(1):69-81. PubMed ID: 20101721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease.
    Suh YH; Checler F
    Pharmacol Rev; 2002 Sep; 54(3):469-525. PubMed ID: 12223532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.
    Sturchler-Pierrat C; Abramowski D; Duke M; Wiederhold KH; Mistl C; Rothacher S; Ledermann B; Bürki K; Frey P; Paganetti PA; Waridel C; Calhoun ME; Jucker M; Probst A; Staufenbiel M; Sommer B
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13287-92. PubMed ID: 9371838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amyloid peptide and its precursor in Alzheimer's disease.
    Octave JN
    Rev Neurosci; 1995; 6(4):287-316. PubMed ID: 8845971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Familial forms of Alzheimer's disease].
    Maréchal L; Campion D; Hannequin D
    Presse Med; 2003 May; 32(16):756-63. PubMed ID: 12856536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches.
    Van Broeck B; Van Broeckhoven C; Kumar-Singh S
    Neurodegener Dis; 2007; 4(5):349-65. PubMed ID: 17622778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Animal Model to Test Reversal of Cognitive Decline Associated with Beta-Amyloid Pathologies.
    Deba F; Peterson S; Hamouda AK
    Methods Mol Biol; 2019; 2011():393-412. PubMed ID: 31273712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.
    Vanden Dries V; Stygelbout V; Pierrot N; Yilmaz Z; Suain V; De Decker R; Buée L; Octave JN; Brion JP; Leroy K
    Neurobiol Aging; 2017 Jul; 55():202-212. PubMed ID: 28464981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse models of Alzheimer's disease: a quest for plaques and tangles.
    Richardson JA; Burns DK
    ILAR J; 2002; 43(2):89-99. PubMed ID: 11917160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic mouse models of Alzheimer's disease.
    Bornemann KD; Staufenbiel M
    Ann N Y Acad Sci; 2000 Jun; 908():260-6. PubMed ID: 10911965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
    Xu BG; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.
    Grueninger F; Bohrmann B; Czech C; Ballard TM; Frey JR; Weidensteiner C; von Kienlin M; Ozmen L
    Neurobiol Dis; 2010 Feb; 37(2):294-306. PubMed ID: 19781645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.
    Kulnane LS; Lamb BT
    Neurobiol Dis; 2001 Dec; 8(6):982-92. PubMed ID: 11741394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
    Götz J; Schild A; Hoerndli F; Pennanen L
    Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.
    Crews L; Rockenstein E; Masliah E
    Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice.
    Hartmann J; Erb C; Ebert U; Baumann KH; Popp A; König G; Klein J
    Neuroscience; 2004; 125(4):1009-17. PubMed ID: 15120860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.